Cue Biopharma (CUE)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
228,175,000
EV to revenue ratio (TTM)
5.71
EV to ebitda
-1.76
Financial Performance
Revenue (TTM)
37,655,000
Gross profit (TTM)
-37,335,000
EBITDA
-97,284,000
Profitability
Operating margin (TTM)
-1,113.00%
Profit margin
0.00%
Return on assets (TTM)
-172.70%
Return on equity (TTM)
-1,603.00%
Per Share Metrics
Revenue per share (TTM)
8.31
EPS
-29.24
Diluted EPS (TTM)
-29.24
Book value
0.44
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
6.06
Price to book ratio (TTM)
99.22
Growth
Quarterly earnings growth (YoY)
166.70%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
0
Buy
2
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
2.459